News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
265,859 Results
Type
Article (14165)
Company Profile (282)
Press Release (251412)
Section
Business (79542)
Career Advice (154)
Deals (13235)
Drug Delivery (35)
Drug Development (50431)
Employer Resources (31)
FDA (5714)
Job Trends (5134)
News (144435)
Policy (10033)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (11)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (7)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (4)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (910)
Accelerated approval (2)
Adcomms (12)
Allergies (49)
Alliances (21649)
ALS (57)
Alzheimer's disease (813)
Antibody-drug conjugate (ADC) (79)
Approvals (5720)
Artificial intelligence (103)
Autoimmune disease (8)
Automation (5)
Bankruptcy (104)
Best Places to Work (4567)
BIOSECURE Act (5)
Biosimilars (38)
Biotechnology (232)
Bladder cancer (40)
Brain cancer (19)
Breast cancer (135)
Cancer (1187)
Cardiovascular disease (95)
Career advice (133)
Career pathing (2)
CAR-T (102)
Cell therapy (295)
Cervical cancer (5)
Clinical research (40741)
Collaboration (476)
Compensation (206)
Complete response letters (13)
COVID-19 (1030)
CRISPR (35)
C-suite (131)
Cystic fibrosis (75)
Data (1236)
Denatured (11)
Depression (28)
Diabetes (113)
Diagnostics (1289)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (75)
Drug pricing (27)
Drug shortages (3)
Duchenne muscular dystrophy (66)
Earnings (29451)
Editorial (16)
Employer branding (4)
Employer resources (29)
Events (47960)
Executive appointments (384)
FDA (6279)
Featured Employer (32)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (440)
Gene editing (83)
Generative AI (9)
Gene therapy (218)
GLP-1 (345)
Government (1074)
Grass and pollen (2)
Guidances (18)
Healthcare (6591)
Huntington's disease (21)
IgA nephropathy (19)
Immunology and inflammation (72)
Indications (17)
Infectious disease (1086)
Inflammatory bowel disease (109)
Inflation Reduction Act (8)
Influenza (16)
Intellectual property (52)
Interviews (17)
IPO (7264)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (4)
Layoffs (198)
Leadership (3)
Legal (1387)
Liver cancer (30)
Lung cancer (169)
Lymphoma (78)
Machine learning (1)
Management (7)
Manufacturing (110)
MASH (46)
Medical device (2591)
Medtech (2592)
Mergers & acquisitions (6238)
Metabolic disorders (344)
Multiple sclerosis (48)
NASH (13)
Neurodegenerative disease (53)
Neuropsychiatric disorders (22)
Neuroscience (1162)
NextGen: Class of 2025 (2016)
Non-profit (855)
Northern California (1441)
Now hiring (21)
Obesity (181)
Opinion (100)
Ovarian cancer (50)
Pain (39)
Pancreatic cancer (49)
Parkinson's disease (99)
Partnered (6)
Patents (101)
Patient recruitment (59)
Peanut (35)
People (25463)
Pharmaceutical (48)
Pharmacy benefit managers (5)
Phase I (14377)
Phase II (18954)
Phase III (11984)
Pipeline (594)
Podcasts (43)
Policy (34)
Postmarket research (852)
Preclinical (6022)
Press Release (30)
Prostate cancer (50)
Psychedelics (35)
Radiopharmaceuticals (210)
Rare diseases (265)
Real estate (1414)
Recruiting (12)
Regulatory (8511)
Reports (14)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (3)
RNA editing (2)
RSV (10)
Schizophrenia (54)
Series A (86)
Series B (52)
Service/supplier (1)
Sickle cell disease (37)
Southern California (1286)
Special edition (11)
Sponsored (11)
Startups (1970)
State (1)
Stomach cancer (4)
Supply chain (18)
The Weekly (32)
United States (11439)
Vaccines (199)
Venture capitalists (27)
Webinars (7)
Weight loss (101)
Women's health (14)
Worklife (2)
Date
Today (68)
Last 7 days (353)
Last 30 days (1737)
Last 365 days (20182)
2025 (3820)
2024 (20559)
2023 (22420)
2022 (26835)
2021 (27816)
2020 (23384)
2019 (16248)
2018 (11770)
2017 (13768)
2016 (11850)
2015 (14358)
2014 (10395)
2013 (7487)
2012 (7543)
2011 (7617)
2010 (7431)
Location
Africa (148)
Alabama (37)
Alaska (2)
Arizona (50)
Arkansas (5)
Asia (17166)
Australia (2906)
California (3305)
Canada (1017)
China (293)
Colorado (127)
Connecticut (141)
Delaware (85)
Europe (36925)
Florida (385)
Georgia (99)
Idaho (16)
Illinois (200)
India (7)
Indiana (83)
Iowa (1)
Japan (65)
Kansas (58)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (428)
Massachusetts (2617)
Michigan (68)
Minnesota (128)
Mississippi (1)
Missouri (22)
Montana (14)
Nebraska (4)
Nevada (14)
New Hampshire (13)
New Jersey (834)
New Mexico (12)
New York (909)
North Carolina (502)
North Dakota (4)
Northern California (1441)
Ohio (102)
Oklahoma (8)
Oregon (21)
Pennsylvania (630)
Puerto Rico (2)
Rhode Island (13)
South America (207)
South Carolina (3)
Southern California (1286)
Tennessee (24)
Texas (372)
Utah (47)
Virginia (66)
Washington D.C. (28)
Washington State (308)
Wisconsin (13)
265,859 Results for "maverick therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Beyeonics Surgical Announces the First Use of the Beyeonics Maverick System in Surgery
The Beyeonics™ Maverick system has been used in surgery for the first time to successfully give surgeons enhanced visual and operational capabilities during neurosurgical and orthopedic procedures.
May 20, 2024
·
2 min read
Press Releases
Maverick Medical AI Announces Completion of The Implementation of Its Real-Time Autonomous Medical Coding Solution at RadNet
December 1, 2024
·
3 min read
Genetown
908 Devices Launches MAVERICK for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters
908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the launch of MAVERICK.
September 18, 2023
·
6 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Drug Development
Sorrento Announces FDA Authorization to Proceed With Phase 2 Study of Abivertinib (Fujovee™) to Treat Metastatic Castrate Resistant Prostate Cancer (MAVERICK Trial)
Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) today announced that it has received clearance from the FDA for its investigational new drug application (IND) for Abivertinib (Fujovee™) for the Phase 2 MAVERICK study to be conducted in participants with metastatic castrate resistant prostate cancer (mCRPC) at multiple centers in the United States.
May 17, 2022
·
7 min read
Layoffs
Repare Therapeutics to Cut Staff Again, This Time by 75%
The latest Repare Therapeutics layoffs will include its chief medical officer and could leave the biotech with fewer than 35 employees as it works to advance two Phase I clinical programs.
February 25, 2025
·
2 min read
·
Angela Gabriel
Drug Development
Allakos Announces Phase 2 Lirentelimab Trials in Atopic Dermatitis and Chronic Spontaneous Urticaria Did Not Meet Their Primary Endpoints
Allakos Inc. today announced topline data from its phase 2 clinical trial in patients with atopic dermatitis (ATLAS) and from its Phase 2b clinical trial in patients with chronic spontaneous urticaria (MAVERICK).
January 16, 2024
·
6 min read
Deals
Takeda to Acquire Maverick Therapeutics to Advance T-Cell Engager Therapies for Solid Tumors and Expand Novel Immuno-Oncology Portfolio
Acquisition expands Takeda’s immuno-oncology portfolio with two development candidates and Maverick’s conditionally active bispecific T-cell engagers COBRA™ platform, specifically designed to target solid tumors Maverick’s lead candidate TAK-186 (formerly MVC-101), a conditionally active T-cell engager, is first in its class to enter the clinic with recent Phase 1/2 study initiation
March 9, 2021
·
10 min read
Press Releases
Areteia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday January 14, 2025
January 9, 2025
·
3 min read
Biotech Bay
Anitoa Receives FDA Registration and Class II Exempt Device Listing for its Maverick Line of Portable qPCR Instruments
Anitoa Systems, LLC., a Silicon Valley biotechnology company and market leader in rapid, portable molecular testing hardware, today announced its Maverick line of qPCR instruments have received US FDA registration and device listing as class II 510(k) exempt medical device.
October 26, 2021
·
2 min read
1 of 26,586
Next